Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Switch to English

8301	Sociétés
115073	Mots-clés
55422	Articles
62513	Communiqués

Accueil
Sociétés
Medicure, Inc.

COMMUNIQUÉ DE PRESSE

publié le 23/04/2024 à 23:00, il y a 6 mois 27 jours

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRÈVE

publiée le 08/04/2024 à 23:05, il y a 7 mois 12 jours

Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre

Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRÈVE

publiée le 08/04/2024 à 23:05, il y a 7 mois 12 jours

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
COMMUNIQUÉ DE PRESSE

publié le 08/04/2024 à 23:00, il y a 7 mois 12 jours

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis
BRÈVE

publiée le 05/04/2024 à 00:05, il y a 7 mois 16 jours

Medicure Inc. to Announce 2023 Financial Results in Upcoming Conference Call

Financial Results Conference Call Pharmaceutical Industry Medicure Inc. 2023 Year End
BRÈVE

publiée le 05/04/2024 à 00:05, il y a 7 mois 16 jours

Medicure Inc. annoncera ses résultats financiers pour 2023 lors d'une prochaine conférence téléphonique

Résultats Financiers Medicure Inc. Conférence Téléphonique Fin D'année 2023 Industrie Pharmaceutique
COMMUNIQUÉ DE PRESSE

publié le 05/04/2024 à 00:00, il y a 7 mois 16 jours

Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
Medicure Inc. to present 2023 Year End Financial Results on April 9, 2024, focusing on pharmaceuticals and healthcare products. Conference call details provided

Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2023 Year End Financial Results
COMMUNIQUÉ DE PRESSE

publié le 05/12/2023 à 23:00, il y a 11 mois 15 jours

Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
Medicure Inc. announces a partnership with TheracosBio through Marley Drug to distribute BRENZAVVY, a new diabetes drug, at an affordable cash price, aiming to improve patient care in the US

Medicure Inc. TheracosBio BRENZAVVY Diabetes Drug Marley Drug
COMMUNIQUÉ DE PRESSE

publié le 23/11/2023 à 23:00, il y a 11 mois 27 jours

Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
COMMUNIQUÉ DE PRESSE

publié le 21/11/2023 à 23:00, il y a 11 mois 29 jours

Medicure Reports Financial Results for Quarter Ended September 30, 2023

Les Echos

Publié le 21/11/2024 à 06:58, il y a 11 heures 59 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 11 heures 59 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 11 heures 59 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 22 heures 49 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 23 heures 37 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 17:35, il y a 1 heure 22 minutes

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Publié le 21/11/2024 à 17:30, il y a 1 heure 27 minutes

SimpliGov and Proof Partner to Offer Online Notarization
Publié le 21/11/2024 à 16:30, il y a 2 heures 27 minutes

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Publié le 21/11/2024 à 16:01, il y a 2 heures 56 minutes

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Publié le 21/11/2024 à 16:00, il y a 2 heures 57 minutes

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 18:36, il y a 21 minutes

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Publié le 21/11/2024 à 17:58, il y a 58 minutes

Funding Circle Plc: POS-Transaction in Own Shares
Publié le 21/11/2024 à 17:51, il y a 1 heure 5 minutes

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Publié le 21/11/2024 à 17:51, il y a 1 heure 5 minutes

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Publié le 21/11/2024 à 17:51, il y a 1 heure 5 minutes

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.